홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Miconazole

HCID 4189
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
22916-47-8
표준 SMILES
Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
InChIKey
BYBLEWFAAKGYCD-UHFFFAOYSA-N
분자식
C18H14Cl4N2O
평균 분자량
416.1 g/mol
단동위원소 질량
413.986024

개요

1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole is a member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 2,4-dichlorobenzyl group. It is a dichlorobenzene, a member of imidazoles and an ether.

이름 및 식별자

우선 이름
Miconazole
IUPAC
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
영어명
Miconazole
분자식
C18H14Cl4N2O
분자량
416.13

이름 및 동의어

miconazole22916-47-8Daktarin IVMiconazolMiconazoloMiconazolum1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazoleDaktarinOravig1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-DTXSID6023319
이름 더 보기
MICONAZOLE BASE1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]- (9CI)r18134mjr1762R 18134MinostateNSC 170986Miconozole
7NNO0D7S5M1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole1H-Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-DTXCID803319Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-NSC170986DermazoleDumicoat

데이터베이스 식별자

CAS
22916-47-8
PubChem CID
4189
DTXSID
DTXSID6023319
ChEMBL
CHEMBL91
ChEBI
CHEBI:82892
UNII
7NNO0D7S5M
EC Number
245-324-5
Nikkaji
J11.471E

물성

구조 계산 물성

XLogP
5.3
극성 표면적
27.1 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
2
회전 가능 결합 수
6
무거운 원자 수
25
형식 전하
0
복잡도
417

실험 및 물리화학적 성질

Drugs · 2건

Pharmaceuticals -> Antibiotics

Pharmaceuticals

PesticidesBiocide
LogP · 2건

6.1

5.81

Solubility7.63e-04 g/L
Human Drugs · 4건

Breast Feeding; Lactation; Milk, Human; Antifungal Agents; Dermatologic Agents

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Dermatological medicines > Antifungal medicines

Endocrine DisruptorsPotential endocrine disrupting compound
Melting Point159 - 163 °C
Physical DescriptionSolid
Collision Cross Section187.51 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
159 · 159-163C
끓는 점
555.1 · 555.1±50.0 °C(Predicted)
밀도
1.5326 · 1.5326 (rough estimate)
굴절률
1.62 · 1.6200 (estimate)
인화점
87 ° · 87°(189°F)
저장 조건
Sealed in dry,Room Temperature
용해도
물에 아주 약간 용해되고, 메탄올에 쉽게 용해되고, 에탄올에 용해됩니다(96%).
물리적 상태
Solid
산도 계수 (pKa)
6.91 · pKa 6.91(H2O,t =25) (Uncertain)
색상
흰색에서 황백색까지
수용성
알코올이나 아세톤에 자유롭게 용해됩니다. DMF나 클로로포름에도 용해됩니다. 물에 불용성
주요 응용
의약품(소분자)
InChI
1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2
InChIKey
BYBLEWFAAKGYCD-UHFFFAOYSA-N
SMILES
Clc1c(ccc(c1)Cl)C(OCc3c(cc(cc3)Cl)Cl)C[n]2cncc2
NIST
Miconazole(22916-47-8)
EPA
1 H-Imidazole, · 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]- (22916-47-8)

화학적 성질

White or almost white powder.

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 5건

This chemical does not meet GHS hazard criteria for 1% (1 of 104) of reports.

Warning

H302 (98.1%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P273, P301+P317, P330, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 104 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory InformationMiconazole: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Other Safety InformationIMAP assessments - 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (98.1%)

독성 정보

Exposure RoutesTopical
Toxicity Summary · 1건

Miconazole interacts with 14-α demethylase, a cytochrome P-450 enzyme necessary to convert lanosterol to ergosterol. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Miconazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms, inhibit purine uptake, and impair triglyceride and/or phospholipid biosynthesis.

Signs and SymptomsIngestion of the amounts of the components contained in a tube of cream are unlikely to produce overdosage and toxic effects.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 5건

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

miconazole

DILI Negative

Topical

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation · 2건

◉ Summary of Use during Lactation

◈ What is miconazole?

Toxicity DataLD50: 3800 mg/kg (Oral, Mouse) (A308) LD50: 3 gm/kg (Oral, Rat) (A308)
EPA Human Health Benchmarks for Pharmaceuticals · 6건

Miconazole

1.2

4.9

The recommended dosing schedule for miconazole is the application of one 50 mg buccal tablet to the upper gum region (canine fossa) once daily for 14 consecutive days.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 50 mg/day, Lowest Therapeutic Dose (LTD): 0.6 mg/kg-day, and Screening Dose: 0.0002 mg/kg-day.

1-Jan-22

안전 데이터

wgk
3
ridadr
3249
HS 번호
2933290000
risk_code
22
hazard_code
Xn
safety_code
22-36
포장분류
III
위험 등급
6.1(b)
Hazard Classifications
Acute Tox. 4 OralAquatic Chronic 4
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

ATC Code · 6건

D01AC02

D - Dermatologicals

S - Sensory organs

G - Genito urinary system and sex hormones

J - Antiinfectives for systemic use

A - Alimentary tract and metabolism

Protein Binding_In vitro_ data suggests that miconazole binds human serum albumin, however, the clinical significance of this observation is unclear.
Pharmacodynamics · 1건

Miconazole is an azole antifungal that functions primarily through inhibition of a specific demethylase within the CYP450 complex. As miconazole is typically applied topically and is minimally absorbed into the systemic circulation following application, the majority of patient reactions are limited to hypersensitivity and cases of anaphylaxis. Patients using intravaginal miconazole products are advised not to rely on contraceptives to prevent pregnancy and sexually transmitted infections, as well as not to use tampons concurrently.

Mechanism of Action · 1건

Miconazole is an azole antifungal used to treat a variety of conditions, including those caused by _Candida_ overgrowth. Unique among the azoles, miconazole is thought to act through three main mechanisms. The primary mechanism of action is through inhibition of the CYP450 14α-lanosterol demethylase enzyme, which results in altered ergosterol production and impaired cell membrane composition and permeability, which in turn leads to cation, phosphate, and low molecular weight protein leakage. In addition, miconazole inhibits fungal peroxidase and catalase while not affecting NADH oxidase activity, leading to increased production of reactive oxygen species (ROS). Increased intracellular ROS leads to downstream pleiotropic effects and eventual apoptosis. Lastly, likely as a result of lanosterol demethylation inhibition, miconazole causes a rise in intracellular levels of farnesol. This molecule participates in quorum sensing in _Candida_, preventing the transition from yeast to mycelial forms and thereby the formation of biofilms, which are more resistant to antibiotics. In addition, farnesol is an inhibitor of drug efflux ABC transporters, namely _Candida_ CaCdr1p and CaCdr2p, which may additionally contribute to increased effectiveness of azole drugs.

Biological Half-LifeMiconazole has a terminal half-life of 24 hours.
Metabolism/MetabolitesMiconazole is metabolized in the liver and does not give rise to any active metabolites.
FDA Pharmacological Classification · 6건

7NNO0D7S5M

MICONAZOLE

Established Pharmacologic Class [EPC] - Azole Antifungal

Chemical Structure [CS] - Azoles

Miconazole is an Azole Antifungal.

MICONAZOLE

MeSH Pharmacological Classification · 4건

Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.

Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism.

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C9.

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A.

Absorption, Distribution and Excretion · 3건

Miconazole given to healthy volunteers as a single 50 mg oral tablet produced a mean Cmax of 15.1 ± 16.2 mcg/mL, a mean AUC0-24 of 55.2 ± 35.1 mcg\*h/mL, and a median Tmax of 7 hours (range 2.0-24.1). In these patients measurable plasma concentrations ranged from 0.5 to 0.83 mcg/mL. Topical miconazole is absorbed poorly into the systemic circulation. In pediatric patients aged 1-21 months given multiple topical applications of miconazole ointment for seven days, the plasma miconazole concentration was less than 0.5 ng/mL in 88% of the patients, with the remaining patients having a concentration of 0.57 and 0.58 ng/mL, respectively. Similarly, patients. administered with a vaginal 1200 mg ovule had a mean Cmax of 10.71 ng/mL, mean Tmax of 18.4 hours, and mean AUC0-96 of 477.3 ng\*h/mL.

Miconazole is excreted through both urine and feces; less than 1% of unchanged miconazole is recovered in urine.

A 1200 mg miconazole vaginal suppository resulted in a calculated apparent volume of distribution of 95 546 L while a 100 mg vaginal cream yielded an apparent volume of distribution of 10 911L.

Cellular LocationsCytoplasm

용도 및 제조

Uses · 2건

Use (kg; approx.) in Germany (2009): >1000

For topical application in the treatment of tinea pedis (athlete&rsquo;s foot), tinea cruris, and tinea corporis caused by <i>Trichophyton rubrum</i>, <i>Trichophyton mentagrophytes</i>, and <i>Epidermophyton floccosum</i>, in the treatment of cutaneous candidiasis (moniliasis), and in the treatment of tinea versicolor.

응용 분야 · 1건

용도Antifungal;Sterol 14-demethylase inhibitor. Miconazole (Monistat-Derm, Micatin, etc.) is a synthetic imidazole antifungal compound that acts by altering cell membrane permeability. It is effective against most dermatophyte species, P. orbiculare, and C. albicans.

상·하류 제품 정보

상류 원료

2,4'-디클로로아세토페논2,4-디클로로벤질클로라이드1-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-yl) ethanone(2,4-디클로로페닐)옥시란alpha-(2,4-Dichlorophenyl)-1H-imidazole-1-ethanol2,2',4'-Trichloroacetophenone

하류 제품

SULCONAZOLE

관련 반응

33건
반응 기록 만들기
HRID 200761 반응식
HRID 200761반응물로
HRID 328633 반응식
HRID 328633반응물로
HRID 328634 반응식
HRID 328634반응물로
HRID 328635 반응식
HRID 328635반응물로
HRID 328636 반응식
HRID 328636반응물로
HRID 328637 반응식
HRID 328637반응물로
HRID 328638 반응식
HRID 328638반응물로
HRID 328639 반응식
HRID 328639반응물로
이전1 / 5 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트